Current report 31/2021 – Resolution of the Annual General Meeting on the payment of the dividend

Legal basis Article 56(1)(2) of the Act on Public Offering – current and periodical information

Management Board of Celon Pharma S.A. (the "Company") informs that the Annual General Meeting of the Company ("AGM") held on June 29, 2021 adopted a resolution on the distribution of the Company's net profit for the financial year 2020.

Pursuant to this resolution, the AGM has decided that the Company's net profit for 2020 in the amount of PLN 21,494,827.07 is to be distributed as follows:

a)  PLN 18,344,827.07 is to be allocated to the Company’s reserve capital,

b) PLN 3,150,000.00 is to be paid out to shareholders as dividend, i.e. PLN 0.07 per share.

45,000,000 shares of the Company are covered by the dividend.

The Annual General Meeting of the Company set July 15, 2021 as the dividend record date and August 5, 2021 as the dividend payment date.